SCHEMBL30658773

SCHEMBL30658773

NC1=C(O)C(=O)C(c2ccc3ccccc3c2)O1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.67
KDM4E B2RXH2 2/20 0.67
MAPT P10636 1/20 0.67
CYP3A4 P08684 3/20 0.41
CYP1A2 P05177 2/20 0.41
CYP2C19 P33261 1/20 0.41
ESR1 P03372 1/20 0.38
ESR2 Q92731 1/20 0.38
GSK3B P49841 3/20 0.38
ADK P55263 2/20 0.38
CASP6 P55212 1/20 0.36
SLC6A2 P23975 2/20 0.35
SLC6A4 P31645 2/20 0.35
SLC6A3 Q01959 2/20 0.35
ALDH1A1 P00352 1/20 0.35
HSD17B10 Q99714 1/20 0.35
GRIA3 P42263 1/20 0.35
GRIA4 P48058 1/20 0.35
HTR2C P28335 1/20 0.35
HTR2B P41595 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15619623 0.80 KDM4E (1.00) POLBKDM4EMAPTCYP3A4CYP1A2
SCHEMBL15620022 0.80 MAPT (0.60) POLBKDM4EMAPTCYP3A4CYP1A2
SCHEMBL30658875 0.80 MAPT (0.60) POLBKDM4EMAPTCYP3A4CYP1A2
SCHEMBL30658859 0.78 KDM4E (0.40) POLBKDM4EMAPTGSK3BADK
SCHEMBL15620759 0.78 KDM4E (0.40) POLBKDM4EMAPTGSK3BADK
SCHEMBL29851900 0.77 KDM4E (0.59) POLBKDM4EMAPTCYP3A4CYP1A2
SCHEMBL30658886 0.77 KDM4E (0.59) POLBKDM4EMAPTCYP3A4CYP1A2
SCHEMBL15621079 0.77 KDM4E (0.59) POLBKDM4EMAPTCYP3A4CYP1A2
SCHEMBL15620032 0.76 MAPT (0.67) POLBKDM4EMAPTCYP3A4CYP1A2
SCHEMBL15619911 0.76 KDM4E (0.67) POLBKDM4EMAPTCYP3A4CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110818660-B Beta-hydroxylase inhibitors for the treatment of cancer 罗得岛医院 2023-09-12 CN disclosed